Related Experiment Video
Updated: Aug 4, 2026
08:28
Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
Published on: November 6, 2010
19.3K
Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2
Xuan Liu1, Ming Liu2,3, Li Chen4
1Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, China.
Cell and Tissue Research
|February 25, 2024
Summary
Bone morphogenetic protein 6 (BMP6) counteracts fibrotic changes in retinal pigment epithelial (RPE) cells, a key factor in proliferative vitreoretinopathy (PVR). BMP6 may offer a new therapeutic strategy for PVR by regulating cell proliferation and migration.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Proliferative vitreoretinopathy (PVR) is characterized by epiretinal fibrotic membrane formation by retinal pigment epithelial (RPE) cells.
- Bone morphogenetic protein 6 (BMP6) is known to have antifibrogenic properties.
- The role of BMP6 in PVR pathogenesis, particularly in relation to transforming growth factor-β2 (TGF-β2)-induced RPE cell fibrogenesis, remains unclear.
Purpose of the Study:
- To investigate the relationship between BMP6 and TGF-β2-induced fibrogenesis in RPE cells, an in vitro model for PVR.
- To determine the effect of BMP6 modulation on RPE cell proliferation, migration, epithelial-to-mesenchymal transition (EMT), and extracellular matrix (ECM) remodeling.
- To elucidate the signaling pathways involved in BMP6's action on TGF-β2-stimulated RPE cells.
Main Methods:
- Analysis of BMP6 and TGF-β2 levels in vitreous humor of PVR patients.
- In vitro culture of human RPE cells treated with TGF-β2.
- Overexpression and knockdown of BMP6 in RPE cells.
- Assessment of RPE cell proliferation, migration, EMT, and ECM remodeling.
- Western blot analysis to evaluate the phosphorylation of p38 and JNK MAPK pathways.
- Inhibition of p38 or JNK pathways to assess their role in BMP6-mediated effects.
Main Results:
- BMP6 levels were decreased, while TGF-β2 levels were increased in PVR patient vitreous humor and in TGF-β2-treated RPE cells.
- TGF-β2 treatment significantly increased RPE cell proliferation, migration, EMT, and ECM remodeling.
- BMP6 overexpression inhibited these TGF-β2-induced effects, while BMP6 knockdown exacerbated them.
- BMP6 modulated the phosphorylation of p38 and JNK MAPK pathways in response to TGF-β2.
- Inhibition of p38 or JNK partially reversed the effects of BMP6 knockdown on TGF-β2-induced RPE fibrogenesis.
Conclusions:
- BMP6 acts as a protective factor against TGF-β2-induced fibrogenesis in RPE cells.
- BMP6 mitigates PVR progression by inhibiting RPE cell proliferation, migration, EMT, and ECM remodeling.
- The antifibrotic effects of BMP6 are mediated through the regulation of p38 and JNK MAPK signaling pathways.
- BMP6 represents a potential therapeutic target for PVR treatment.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...